Amino.Desk

KLOW blend (GHK-Cu + BPC-157 + TB-500 + KPV)

Updated Nov 17, 2026 · Clinical review: pending

KLOW is the GLOW blend with a fourth peptide, KPV, added. The usual vial has a fixed ratio that is mostly GHK-Cu by weight. The mixture has never been tested in people, and a mixed vial falls outside the 2026 compounding policy.

What it is

The GLOW blend (GHK-Cu, BPC-157 and TB-500) with the anti-inflammatory peptide KPV added. Some compounders add a fifth peptide, larazotide, which has been studied for intestinal permeability.

Because the ratio is fixed in the vial, you cannot adjust one ingredient without moving all four. KLOW is 62.5% GHK-Cu by weight. If the ingredient you want is BPC-157, you are buying mostly something else.

What the evidence shows

There is no trial of this blend, and no study has shown that the combination does better than its ingredients taken separately.

The evidence that exists applies to each ingredient on its own. For BPC-157 and TB-500 it is almost entirely animal work. Each ingredient's page has its grade and what has been shown.

Legal status

In October 2026, HHS issued an interim policy allowing licensed pharmacies to compound six peptides on prescription: BPC-157, KPV, TB-500, MOTS-c, Epitalon and Semax. One condition is that the compounded product contains a single active ingredient from that list. Law firms that analyzed the policy concluded that products with more than one active ingredient fall outside it.

Three of KLOW's four ingredients are on that list, which is why 2026 looked like the year blends became legitimate. The single-ingredient condition means the mixed vial is still outside the policy, and GHK-Cu is not one of the six. A seller offering KLOW is working outside the policy or is not a licensed compounding pharmacy.

Reported dosing

No dose has been established for this blend.

No human trial has tested it. The mixing tables and schedules published by sellers are their own arithmetic applied to a product nobody has studied. Where we can report dosing for an individual ingredient, it is on that compound's own page, with the source shown.

Safety

Copper accumulates. Most of a KLOW vial is GHK-Cu, which delivers copper with every dose. Long courses are a reason to pay attention to copper and zinc balance, which is a conversation for a clinician.

If you are considering it anyway

Common questions

What is in KLOW?

GHK-Cu, BPC-157, TB-500 and KPV. The most common vial holds 50 mg of GHK-Cu and 10 mg of each of the others.

What is the difference between GLOW and KLOW?

KLOW is the GLOW formula with KPV added as a fourth peptide.

Is KLOW legal?

Not under the October 2026 policy, which allows one active ingredient per compounded product.

Ask an AI about this page

Opens the assistant with a question about this page already typed in. You can edit it before sending.

Ask ChatGPTAsk ClaudeAsk Perplexity

These are outside services. Amino Desk does not control or review their answers, and an AI summary is not medical advice. Check anything important against the sources below.

Sources

All three repair blends are compared on blends and stacks. To keep a private record of what you take, use the dose and progress log.

Free field guide

Forty peptides and GLP-1s: who can legally get what, how strong the evidence is, and what to check before you pay. Plus one short email a week on what changed.

Leave at any time. We do not sell or share your address. Privacy